Skip to main content

Table 1 Shows demographic details of patients, hemodynamic data and main CMR measurements

From: Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease

  Positive DSMR (n = 15) Negative DSMR (n = 10)
Age (years) 66 ± 8 59 ± 12
Female 3 4
Hypertension 15 7
Diabetes mellitus 3 5
Hyperlipedemia 12 4
Known CAD 1 0
Time between DSMR and coronary angiogramm (weeks) 4 ± 12 8 ± 20
Hemodynamic data   
Peak heart rate (bpm) 136 ± 12 143 ± 9
Heart rate at rest (bpm) 66 ± 9 70 ± 9
Peak BP (mmHg) 146/73 ± 28/13 131/68 ± 17/9
BP at rest (mmHg) 141/76 ± 22/14 129/71 ± 15/13
Maximum dobutamine dose (μg/kg/min) 36 ± 7 37 ± 5
Atropin dose (ml) 0.6 ± 0.3 0.25 ± 0.04
MRI parameter   
LVEF (%) 61 + 4 62 ± 4
LVEDV (ml) 154 ± 31 143 ± 32
LVESV (ml) 60 ± 14 54 ± 14